BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31024855)

  • 1. A Computed Tomography-Based Radiomic Prognostic Marker of Advanced High-Grade Serous Ovarian Cancer Recurrence: A Multicenter Study.
    Wei W; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wang S; Wang M; Guo Y; Tian J
    Front Oncol; 2019; 9():255. PubMed ID: 31024855
    [No Abstract]   [Full Text] [Related]  

  • 2. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
    Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
    Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
    Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
    Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a prediction model for gross residual in high-grade serous ovarian cancer by combining preoperative assessments of abdominal and pelvic metastases and multiparametric MRI.
    Lu J; Cai S; Wang F; Wu PY; Pan X; Qiang J; Li H; Zeng M
    Acad Radiol; 2023 Sep; 30(9):1823-1831. PubMed ID: 36587996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
    Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
    Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer.
    Chen HZ; Wang XR; Zhao FM; Chen XJ; Li XS; Ning G; Guo YK
    Eur J Radiol; 2021 Dec; 145():110018. PubMed ID: 34773830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
    Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
    Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized CT-based radiomics nomogram preoperative predicting Ki-67 expression in gastrointestinal stromal tumors: a multicenter development and validation cohort.
    Zhang QW; Gao YJ; Zhang RY; Zhou XX; Chen SL; Zhang Y; Liu Q; Xu JR; Ge ZZ
    Clin Transl Med; 2020 Jan; 9(1):12. PubMed ID: 32006200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.
    Wei W; Wang K; Liu Z; Tian K; Wang L; Du J; Ma J; Wang S; Li L; Zhao R; Cui L; Wu Z; Tian J
    Radiother Oncol; 2019 Dec; 141():239-246. PubMed ID: 31668985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer.
    Zhan F; He L; Yu Y; Chen Q; Guo Y; Wang L
    Sci Rep; 2023 Sep; 13(1):16397. PubMed ID: 37773310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.
    Li H; Cai S; Deng L; Xiao Z; Guo Q; Qiang J; Gong J; Gu Y; Liu Z
    Eur Radiol; 2023 Aug; 33(8):5298-5308. PubMed ID: 36995415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of survival predictors for high-grade serous ovarian cancer based on stable radiomic features from computed tomography images.
    Hu J; Wang Z; Zuo R; Zheng C; Lu B; Cheng X; Lu W; Zhao C; Liu P; Lu Y
    iScience; 2022 Jul; 25(7):104628. PubMed ID: 35800777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer.
    Zhang W; Fang M; Dong D; Wang X; Ke X; Zhang L; Hu C; Guo L; Guan X; Zhou J; Shan X; Tian J
    Radiother Oncol; 2020 Apr; 145():13-20. PubMed ID: 31869677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
    Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
    Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative CT Radiomics Predicting the SSIGN Risk Groups in Patients With Clear Cell Renal Cell Carcinoma: Development and Multicenter Validation.
    Jiang Y; Li W; Huang C; Tian C; Chen Q; Zeng X; Cao Y; Chen Y; Yang Y; Liu H; Bo Y; Luo C; Li Y; Zhang T; Wang R
    Front Oncol; 2020; 10():909. PubMed ID: 32850304
    [No Abstract]   [Full Text] [Related]  

  • 18. CT radiomics may predict the grade of pancreatic neuroendocrine tumors: a multicenter study.
    Gu D; Hu Y; Ding H; Wei J; Chen K; Liu H; Zeng M; Tian J
    Eur Radiol; 2019 Dec; 29(12):6880-6890. PubMed ID: 31227882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial CT-based radiomics nomogram for predicting in-hospital mortality in patients with traumatic brain injury: a multicenter development and validation study.
    Zheng RZ; Zhao ZJ; Yang XT; Jiang SW; Li YD; Li WJ; Li XH; Zhou Y; Gao CJ; Ma YB; Pan SM; Wang Y
    Neurol Sci; 2022 Jul; 43(7):4363-4372. PubMed ID: 35199252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
    Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
    Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.